(Press-News.org) Researchers have developed a new strategy to engineer biochar with dramatically enhanced sunlight-driven chemical activity, opening promising pathways for environmental remediation and pollutant transformation. The findings demonstrate how combining biochar with artificially synthesized humic substances can significantly boost its ability to drive light-powered reduction reactions that influence metal cycling and contaminant transformation in natural environments.
The study, recently published in Biochar, introduces a co-engineering approach that integrates biochar with artificial humic substances created through a controlled hydrothermal process using pine sawdust. By carefully adjusting the treatment temperature, the team produced materials with highly tunable chemical structures and electron-donating abilities that directly influence their environmental performance.
Biochar, a carbon-rich material produced from biomass, is widely recognized for its role in soil improvement and pollution control. However, its light-driven chemical behavior has remained poorly understood. Meanwhile, natural humic substances play essential roles in environmental redox reactions, but their complex and slow natural formation makes them difficult to study or apply in engineered systems.
“Our work shows that it is possible to precisely design biochar-based materials with controllable redox activity by co-engineering them with artificial humic substances,” said the study’s corresponding authors. “This approach allows us to accelerate natural humification processes and create materials that actively respond to sunlight.”
To evaluate the performance of the engineered materials, the researchers used silver ion reduction as a model reaction. The experiments revealed that artificial humic substances produced at higher hydrothermal temperatures displayed significantly stronger photochemical performance. Materials synthesized at 340 degrees Celsius demonstrated a reduction efficiency more than nineteen times greater than those produced at lower temperatures.
The improvement stems from structural changes in lignin-derived molecules during hydrothermal treatment. Higher temperatures increased the abundance of phenolic functional groups, which serve as powerful electron donors. When exposed to sunlight, these groups generate superoxide radicals that drive chemical reduction reactions and initiate ligand-to-metal charge transfer pathways.
The researchers also discovered a previously overlooked phenomenon. Under sunlight, hydrochar undergoes partial dissolution, releasing dissolved organic molecules that further enhance photochemical activity. This dynamic transformation suggests that biochar materials may play more active and evolving roles in environmental systems than previously recognized.
“Our findings highlight that biochar is not just a passive sorbent,” the authors explained. “It can dynamically transform under sunlight and participate in complex photochemical reactions that affect pollutant behavior and metal cycling.”
Beyond improving fundamental scientific understanding, the research offers potential practical applications. The engineered materials could support the development of solar-responsive remediation technologies for contaminated water and soil systems. They may also help scientists better predict the environmental fate of metals and organic pollutants in sunlit natural waters and soils.
Importantly, the artificial humic substances used in the study were derived from waste biomass, providing a sustainable and scalable pathway for material production. This aligns with global efforts to develop carbon-negative technologies and circular bioeconomy solutions.
The researchers suggest that future studies could explore broader pollutant classes and natural environmental conditions, helping translate laboratory discoveries into real-world environmental technologies.
By demonstrating how molecular structure design can control sunlight-driven environmental reactions, this work marks a major step toward advanced functional biochar materials capable of addressing pressing environmental challenges.
===
Journal Reference: Sun, L., Shen, M., Jia, C. et al. Co-engineering biochar and artificial humic substances: advancing photoreduction performance through structure design. Biochar 8, 12 (2026).
https://doi.org/10.1007/s42773-025-00526-3
===
About Biochar
Biochar (e-ISSN: 2524-7867) is the first journal dedicated exclusively to biochar research, spanning agronomy, environmental science, and materials science. It publishes original studies on biochar production, processing, and applications—such as bioenergy, environmental remediation, soil enhancement, climate mitigation, water treatment, and sustainability analysis. The journal serves as an innovative and professional platform for global researchers to share advances in this rapidly expanding field.
Follow us on Facebook, X, and Bluesky.
END
Scientists design solar-responsive biochar that accelerates environmental cleanup
2026-02-06
ELSE PRESS RELEASES FROM THIS DATE:
Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases
2026-02-06
https://doi.org/10.1016/j.apsb.2025.09.014
This new article publication from Acta Pharmaceutica Sinica B, discusses the construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases.
Vaccines represent one of the most potent strategies for protecting humans from the threat of infectious diseases. Conventional vaccines elicit acquired immunity by mimicking pathogen characteristics; however, their protective efficacy is limited by inadequate spatiotemporal control of ...
Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy
2026-02-06
https://doi.org/10.1016/j.apsb.2025.10.005
This new article publication from Acta Pharmaceutica Sinica B, discusses the deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy.
Phenotypic screening has played an important role in discovering innovative small-molecule drugs and clinical candidates with unique molecular mechanisms of action. However, conducting cell-based high-throughput screening from vast compound libraries is extremely time-consuming and expensive. Fortunately, deep learning has provided a new paradigm for identifying ...
DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer
2026-02-06
https://doi.org/10.1016/j.apsb.2025.10.031
This new article publication from Acta Pharmaceutica Sinica B, discusses DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer.
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, characterized by the poorest prognosis, and poses a significant threat to women's health. In this study two novel prieurianin-type limonoids extracted from Munronia henryi were identified, one of which, named DHL-11, exhibited antitumor activity ...
Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model
2026-02-06
https://doi.org/10.1016/j.apsb.2025.09.026
This new article publication from Acta Pharmaceutica Sinica B, discusses the discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model.
SARS-CoV-2 continues to propagate globally, posing non-negligible risks of severe COVID-19. Although several clinical antivirals and immunosuppressants offer crucial protection, there is a persistent need for additional therapeutic options to counter emerging viral variants and drug ...
Neg-entropy is the true drug target for chronic diseases
2026-02-06
https://doi.org/10.1016/j.apsb.2025.11.026
This new article publication from Acta Pharmaceutica Sinica B, discusses how neg-entropy is the true drug target for chronic diseases.
Molecular mechanisms of chronic diseases are complicated, and this impedes drug target identification and subsequent drug discovery. Entropy increase in human body can be considered the root cause of chronic diseases. Accordingly, the inherent neg-entropic mechanisms, for instance the homeostatic mechanisms for metabolism, immunity, self-healing, etc., are true drug targets. Only very few ...
Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis
2026-02-06
https://doi.org/10.1016/j.apsb.2025.09.037
This new article publication from Acta Pharmaceutica Sinica B, discusses an Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis.
Psoriasis is a prevalent chronic inflammatory skin disorder, characterized by epidermal thickening and an inflammatory hypoxic microenvironment, which significantly hinder drug penetration through the thickened skin and limit the efficacy of photodynamic therapy (PDT). The authors of this article ...
Early TB treatment reduced deaths from sepsis among people with HIV
2026-02-06
Sepsis is a leading global cause of hospital deaths, occurring when the body’s response to infection damages tissue and causes organs to fail. Africa bears the world’s highest burden of sepsis, with an estimated 48 million cases each year leading to about 11 million deaths. People living with HIV face the greatest risk of dying from the condition.
A new study has found that tuberculosis, a chronic bacterial lung disease, is a major and long-overlooked cause of deadly sepsis among people living with HIV. An associated Phase 3 clinical trial called the ATLAS study found that starting tuberculosis (TB) treatment ...
Palmitoylation of Tfr1 enhances platelet ferroptosis and liver injury in heat stroke
2026-02-06
https://doi.org/10.1016/j.apsb.2025.10.027
This new article publication from Acta Pharmaceutica Sinica B, discusses how palmitoylation of Tfr1 enhances platelet ferroptosis and liver injury in heat stroke.
Heat stroke (HS) is a severe medical emergency characterized by coagulation and high mortality due to organ injury. This study identifies a novel mechanism in which platelet ferroptosis, driven by transferrin receptor 1 (Tfr1) palmitoylation, significantly contributes to liver injury in HS. ...
Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity
2026-02-06
https://doi.org/10.1016/j.apsb.2025.10.028
This new article publication from Acta Pharmaceutica Sinica B, discusses how structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity.
Recent advances in ion channel structural biology have enhanced structure-based drug design, yet lipid-occupied binding pockets—often large and flat—remain a major hurdle for developing selective small molecules. TRPC5, a brain-enriched channel regulating depression and anxiety, is a promising therapeutic target, but current preclinical candidates suffer from moderate off-target effects. To address ...
Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guidelines
2026-02-06
https://doi.org/10.1016/j.apsb.2025.11.025
This new article publication from Acta Pharmaceutica Sinica B, discusses therapeutic drug monitoring of biologics in inflammatory bowel disease.
Therapeutic drug monitoring (TDM) has emerged as a valuable tool for optimizing the use of biologics in inflammatory bowel disease (IBD). However, variations in focus, methodology, and recommendations among relevant guidelines and consensuses have contributed to inconsistencies in their quality. This guideline synthesizes current evidence to standardize TDM of biologics in IBD and improve patient ...